Affiliation: NPS Pharmaceuticals
- Population pharmacokinetics of teduglutide following repeated subcutaneous administrations in healthy participants and in patients with short bowel syndrome and Crohn's diseaseJean Francois Marier
Pharsight, a Certara Company, Montreal, QC, Canada
J Clin Pharmacol 50:36-49. 2010..The population PK model will help to support adequate drug labeling following SC administrations in patients and determine whether an individualized dosage is required...